627

· Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for 627, covering 2025-07-15 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC [Phase 2]